Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The University of Texas Health Science Center, Houston
With
Merck Sharp & Dohme LLC
This study will include 380 women aged 18-50 enrolled between 28 weeks gestation and postpartum day #1 who have a pregnancy that is considered high-risk. After consent, participants will be randomized to either routine care or multimedia based intervention. The intervention will include an investigator created decision aid presented at the time of randomization and reminder texts until 12 weeks postpartum.
The primary objective is to evaluate the rate of LARC uptake and retention within 12 weeks of delivery. Secondary objectives include i) the retention of LARC at 12 and 24 months and ii) short-interval pregnancy rates.
Age
13–50
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Aged 13-50 years old
High risk pregnancy due to either maternal medical conditions or obstetric/neonatal complications
You may not be if
Planned cesarean hysterectomy
Unable to provide informed consent in either English or Spanish
Unable to provide reliable cell phone access for the study duration
Not willing to provide follow-up for two years
Clareo Health | Use of an Educational Multimedia Tool Versus Routine Care for the Uptake of Postpartum LARC in High-Risk Pregnancies
